T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
XYZ
Block, Inc.
XYZ
|
$2.23B |
| 2 |
Carvana
CVNA
|
$1.65B |
| 3 |
Microsoft
MSFT
|
$1.46B |
| 4 |
Affirm
AFRM
|
$1.2B |
| 5 |
Walt Disney
DIS
|
$1.18B |
Top Sells
| 1 |
Visa
V
|
$2.51B |
| 2 |
Intuit
INTU
|
$2.08B |
| 3 |
Match Group
MTCH
|
$1.93B |
| 4 |
Salesforce
CRM
|
$1.88B |
| 5 |
Meta Platforms (Facebook)
META
|
$1.52B |
Sector Composition
| 1 | Technology | 25.2% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.34% |
| 4 | Communication Services | 13.81% |
| 5 | Financials | 12.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Cummins
CMI
$55.1B
| $565M | 0.05% |
2,517,053
-2,067,097
| -45% | -$464M |
|
327
GSK
GSK
$81.5B
| $565M | 0.05% |
11,822,494
+87,602
| +0.7% | +$4.18M |
|
328
FirstEnergy
FE
$25.1B
| $564M | 0.05% |
15,842,156
+492,184
| +3% | +$17.5M |
|
329
Devon Energy
DVN
$22.1B
| $562M | 0.05% |
15,833,026
-16,825,397
| -52% | -$597M |
|
330
Amgen
AMGN
$153B
| $557M | 0.05% |
2,621,390
-99,938
| -4% | -$21.3M |
|
331
PTC
PTC
$25.6B
| $549M | 0.05% |
4,583,570
+951,346
| +26% | +$114M |
|
332
Webster Financial
WBS
$10.3B
| $546M | 0.05% |
10,021,502
-393,107
| -4% | -$21.4M |
|
|
NVRO
333
DELISTED
NEVRO CORP.
NVRO
| $544M | 0.05% |
4,671,765
+226
| +0% | +$26.3K |
|
334
Crown Castle
CCI
$41.9B
| $540M | 0.05% |
3,113,535
-227,338
| -7% | -$39.4M |
|
335
Vimeo
VMEO
$734M
| $538M | 0.05% |
18,323,791
-1,098,862
| -6% | -$32.3M |
|
336
Travelers Companies
TRV
$62B
| $535M | 0.05% |
3,518,365
+1,031,007
| +41% | +$157M |
|
337
Trade Desk
TTD
$25.5B
| $523M | 0.05% |
7,442,645
+6,379,951
| +600% | +$449M |
|
338
Endava
DAVA
$553M
| $522M | 0.05% |
3,845,249
+482,128
| +14% | +$65.5M |
|
339
Pinnacle Financial Partners
PNFP
$7.55B
| $513M | 0.05% |
5,454,761
-240,602
| -4% | -$22.6M |
|
340
Micron Technology
MU
$147B
| $511M | 0.05% |
7,194,876
+1,782,981
| +33% | +$127M |
|
341
Littelfuse
LFUS
$6.51B
| $507M | 0.05% |
1,855,941
+218,630
| +13% | +$59.7M |
|
342
EQT Corp
EQT
$32.2B
| $505M | 0.05% |
24,679,560
-3,983,390
| -14% | -$81.5M |
|
343
Biogen
BIIB
$20.6B
| $505M | 0.05% |
1,784,136
+171,573
| +11% | +$48.6M |
|
344
BWX Technologies
BWXT
$15B
| $503M | 0.05% |
9,346,644
-465,786
| -5% | -$25.1M |
|
345
Flowers Foods
FLO
$3.13B
| $500M | 0.05% |
21,143,953
+527,939
| +3% | +$12.5M |
|
346
Dollar Tree
DLTR
$20.6B
| $498M | 0.05% |
5,202,312
-4,305,297
| -45% | -$412M |
|
347
AXIS Capital
AXS
$7.62B
| $494M | 0.05% |
10,737,002
+127,443
| +1% | +$5.87M |
|
348
SBA Communications
SBAC
$21.2B
| $493M | 0.05% |
1,491,263
+89,978
| +6% | +$29.7M |
|
|
KL
349
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $492M | 0.05% |
11,822,897
+13,925
| +0.1% | +$579K |
|
350
Regeneron Pharmaceuticals
REGN
$60.8B
| $490M | 0.05% |
809,840
-15,004
| -2% | -$9.08M |
|